Design and Development of Small-Molecule Arylaldoxime/5-Nitroimidazole Hybrids as Potent Inhibitors of MARK4: A Promising Approach for Target-Based Cancer Therapy
2014 ◽
Vol 15
(12)
◽
pp. 1635-1645
◽
Keyword(s):
2014 ◽
Vol 349
(3)
◽
pp. 458-469
◽
Keyword(s):
Keyword(s):
Keyword(s):